Occupational asthma

Snashall, D.
October 2003
Occupational & Environmental Medicine;Oct2003, Vol. 60 Issue 10, p711
Academic Journal
Discusses the attempts made by the British government to reduce occupational asthma. Key programs in a reduction strategy; Features of an approved code of practice which aimed to control substances that cause the disease; Introduction of ideas for reducing asthma at work.


Related Articles

  • Managing Asthma in the Workplace. Carroll, Patricia; Wachs, Joy E. // AAOHN Journal;Nov2004, Vol. 52 Issue 11, p481 

    Provides an overview on managing asthma in the workplace. Classifications of asthma severity; Recommended asthma medications; Role of occupational health nurses.

  • Once daily oral controller therapy with low dose theophylline or montelukast was not effective in poorly controlled asthma.  // Evidence Based Medicine;Aug2007, Vol. 12 Issue 4, p115 

    The article comments on a study which examines whether adding once daily oral controller therapy to low dose theophylline or montelukast improves patient with poorly controlled asthma. The study found that once daily oral controller therapy with low dose theophylline or montelukast was not...

  • Pulling The Plug On Triggers: How To Send Asthma Allergens And Irritants Down The Drain. Madden, Julie A. // Internet Journal of Academic Physician Assistants;2002, Vol. 2 Issue 2, p15 

    Asthma is a condition in which the air passages in lungs, called bronchial tubes, are very sensitive to certain substances and are prone to becoming inflamed. It is important to identify triggers that can cause an asthma episode. Allergens are major cause of asthma. People with persistent asthma...

  • Overdiagnosis of asthma in obese and nonobese adults. Aaron, Shawn D.; Vandemheen, Katherine L.; Boulet, Louis-Philippe; McIvor, R. Andrew; FitzGerald, J. Mark; Hernandez, Paul; Lemiere, Catherine; Sharma, Sat; Field, Stephen K.; Alvarez, Gonzalo G.; Dales, Robert E.; Doucette, Steve; Fergusso, Dean // CMAJ: Canadian Medical Association Journal;11/18/2008, Vol. 179 Issue 11, p1121 

    Background: It is unclear whether asthma is overdiagnosed in developed countries, particularly among obese individuals, who may be more likely than nonobese people to experience dyspnea. Methods: We conducted a longitudinal study involving nonobese (body mass index 20-25) and obese (body mass...

  • Comparative Efficacy of Budesonide by Different Delivery Devices in Bronchial Asthma. Rizvi, Dilshad Ali; Salman, Mohammad Tariq; Mahmood, Syed Esam; Sircar, Joydeep; Ansari, Karim Ullah; Verma, Vinod Kumar // National Journal of Physiology, Pharmacy & Pharmacology;2012, Vol. 2 Issue 2, p99 

    Aims& Objective: To assess the relative efficiency of budesonide administered from different delivery devices to adult patients of chronic stable bronchial asthma as measured by pulmonary function test parameters. Materials and Methods: This prospective study was undertaken to assess the...

  • β -Agonists and Asthma: too much of a good thing? Shore, Stephanie A.; Drazen, Jeffrey M. // Journal of Clinical Investigation;Aug2003, Vol. 112 Issue 4, p495 

    Describes a possible mechanism for the worsening of asthma due to β-agonists and reveals a therapeutic target in the treatment of the disease. Description and function of β-agonists; Effect of too much β-agonists; Reason for the adverse effects of β-agonists.

  • Relieving Asthma and Allergies.  // Medical Update;2003, Vol. 28 Issue 11, p1 

    Presents information on managing asthma and nasal allergies. Distinction between nasal allergies and asthma; Recommended treatment for asthma; Treatment for nasal allergies or allergic rhinitis; Ways to reduce exposure to allergic triggers in the home.

  • Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model. Rossi, Elina M.; Pylkkänen, Lea; Koivisto, Antti J.; Nykäsenoja, Heli; Wolff, Henrik; Savolainen, Kai; Alenius, Harri // Particle & Fibre Toxicology;2010, Vol. 7, p35 

    Background: Nanotechnology and engineered nanomaterials (ENM) are here to stay. Recent evidence suggests that exposure to environmental particulate matter exacerbates symptoms of asthma. In the present study we investigated the modulatory effects of titanium dioxide particle exposure in an...

  • Identification of microRNAs associated with allergic airway disease using a genetically diverse mouse population. Rutledge, Holly; Baran-Gale, Jeanette; de Villena, Fernando Pardo-Manuel; Chesler, Elissa J.; Churchill, Gary A.; Sethupathy, Praveen; Kelada, Samir N. P. // BMC Genomics;Aug2015, Vol. 16 Issue 1, p1 

    Background: Allergic airway diseases (AADs) such as asthma are characterized in part by granulocytic airway inflammation. The gene regulatory networks that govern granulocyte recruitment are poorly understood, but evidence is accruing that microRNAs (miRNAs) play an important role. To identify...


Read the Article


Sign out of this library

Other Topics